SANA
Sana Biotechnology, Inc.
Biotechnology · Healthcare · United States
2.57
close · 2026-10-30
value
26
cheaper than peers26
quality
11
stronger fundamentals11
ranked against
Biotechnology (pre-revenue)
value
quality
109 peerswide variation
Value inputs
| measure | company | vs peers |
| earnings yield, 3 years ago | -55.6% | 51 |
| cash flow yield, latest year | -18.8% | 48 |
| earnings yield, 2 years ago | -56.8% | 42 |
| earnings yield, latest year | -37.4% | 42 |
| earnings yield, 1 year ago | -45.1% | 41 |
| cash flow yield, 1 year ago | -33.4% | 36 |
| price to book | 4.98× | 30 |
| cash flow yield, 2 years ago | -35.6% | 29 |
| cash flow yield, 3 years ago | -40.4% | 25 |
9 of 12 measures available
Quality inputs
| measure | company | vs peers |
| operating margin | 0.0% | 50 |
| return on equity | -152.9% | 19 |
| debt to equity | 52.4% | 14 |
3 of 4 measures available
Facts
| market cap | $769M |
| free cash flow | $4.1M |
| employees | 142 |
| first trade | 2021-02-04 |
| next earnings | not reported |
| fundamentals updated | 2026-08-31 |
Annual history
| measure | 2025 | 2024 | 2023 | 2022 |
| diluted eps | -0.96 | -1.16 | -1.46 | -1.43 |
| free cash flow | -$144.8M | -$256.6M | -$273.6M | -$310.9M |
| net income | -$244.2M | -$266.8M | -$283.3M | -$269.5M |
| revenue | $0 | $0 | $0 | $0 |
| unusual items | -$44.6M | -$1.9M | -$7.0M | not reported |